Why is Torrent Pharma falling/rising?

As of 28-Jul, Torrent Pharmaceuticals Ltd. is currently priced at Rs. 3,629.50, reflecting an increase of 21.5 points, or 0.6%. The stock has recently hit a new 52-week high of Rs. 3,633.2 and has outperformed its sector by 0.52%. Over the past two days, the stock has gained 3.49%, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a decline in delivery volume by 8.61% against the 5-day average, the company showcases strong fundamentals, including a high return on capital employed (ROCE) of 22.33% and consistent positive results over the last eight quarters. However, there are concerns regarding its long-term growth, as net sales have only grown at an annual rate of 7.72% over the last five years.
In the broader market context, Torrent Pharmaceuticals has shown a strong performance compared to the benchmark Sensex, with a 1-week return of +3.08% against the Sensex's -1.59% and a 1-month return of +7.54% compared to the Sensex's -3.77%. This indicates that while the overall market is facing challenges, Torrent Pharmaceuticals is managing to attract investor interest and maintain upward momentum. The high institutional holdings at 24.75% suggest confidence from more knowledgeable investors, further supporting the stock's rise despite the noted risks related to its valuation and slower growth in net sales.